Ages Eligible for Study: Ketorolac ophthalmic solution 0. Phosphate buffer pH 7. More Information Responsible Party: Acta Ophthalmol ; 65 Suppl Eligibility Information from the National Library of Medicine Choosing to participate in a study is an important personal decision.
Dissolution medium ml of simulated tear of composition 1 was placed in the beaker and stirred with a star-headed magnetic bead at 60 rpm. In addition to the ionotropic gelling of alginate, its mucoadhesivity is also likely to contribute to enhancement of retention time.
Actions in ocular disease. Indomethacin ophthalmic solution Drug: To determine whether indomethacin 0. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Department of Health and Human Services. Dissolution samples 5 ml were withdrawn as a function of time, and the withdrawn volume was replaced with pre-warmed buffer.
Different types of in situ gelling systems of indomethacin, in sodium alginate vehicle, were prepared and evaluated for their pharmaceutical properties including viscosity, sterility and drug content uniformity.
May 19, First Posted: Ketorolac Ophthalmic Solution Ketorolac 0. Ketorolac Ophthalmic Solution Phase 4. National Institutes of Health U. Cite article How to cite?
Do you have an account?
Subjects who have a history of asthma linked to acetylsalicylic acid or other nonsteroidal anti-inflammatory NSAI drug administration. There were no clinically meaningful safety concerns with either treatment.
A 1 — A 5 Prepared in acetate buffer pH 5. Consequently, the in vivo drug release from these systems could occur primarily by diffusion over a long duration of time, at least similar to, if not greater, than that seen in the in vitro experiments.
Eighteen patients received Indomethacin per-operatively while 16 did not and served as controls. Sears ML, Tarkkanen A. Indomethacin was better tolerated than ketorolac.
Indomethacin Indomethacin ophthalmic solution 0. Ocular tissue reactions to surgical trauma. We are updating the design of this site.